The FTSE 100 has etched a new chapter in UK market history, closing at a record high of 10,341.56 after a 1.15% daily gain. This surge marks the third consecutive day of advances and extends a rally delivering over 20% returns since April 2025 lows, outpacing the S&P 500 and European peers.
Financial stocks spearheaded the rally, with the banking sector hitting levels unseen since before the 2008 crisis. HSBC, Barclays, and NatWest posted solid gains as investors anticipate improved net interest margins from a steepening yield curve. UK gilt yields have risen across maturities, enhancing lenders' pricing power while deposit costs remain stable.
This momentum reflects growing confidence in the UK economy, bolstered by the Bank of England's cautious stance on 2026 rate cuts, allowing banks to capitalise on prolonged elevated rates.
Healthcare and consumer staples also propelled the index higher amid commodities volatility. AstraZeneca rose around 2%, boosting the healthcare sector by 2.6%, thanks to its robust drug pipeline and steady demand. Unilever matched these gains, alongside advances in British American Tobacco, Diageo, Relx, and Compass Group.
Precious metals miners faced pressure, with Endeavour Mining down 7.4%, Fresnillo falling 7.6%, and Antofagasta sliding 5.4%. Industrial miners like Rio Tinto and Glencore stabilised, highlighting a sector divergence.
The FTSE 100's year-to-date gain exceeds 3%, contrasting with the S&P 500's directionless start amid tech valuation worries. The index's weighting in energy, mining, and financials has benefited from commodity strength and higher rates. Sterling's stability at around $1.35 has shielded overseas earnings, while attractive valuations drew institutional investment.
Analysts eye 11,405 as the next target, a 10% upside based on technical projections, following the breakthrough above 10,000. Yet risks loom, including commodity reversals, Bank of England policy shifts, or global trade tensions, urging measured positioning.